Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints

CTLA-4 and PD-1 Pathways

(2016) Elizabeth I. Buchbinder et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Interaction of Serum Antibodies from Breast Cancer Patients with Synthetic Peptides

(2016) S. V. Podlesnykh et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses

(2016) Patrick J. Medina et al.   PHARMACOTHERAPY

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

(2016) Ju Yeon Lee et al.   Nature Communications

Peptide therapeutics: current status and future directions

(2015) Keld Fosgerau et al.   DRUG DISCOVERY TODAY

Immune Checkpoint Blockade in Cancer Therapy

(2015) Michael A. Postow et al.   JOURNAL OF CLINICAL ONCOLOGY

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

Peptide Therapeutics for Treating Ocular Surface Infections

(2014) Curtis R. Brandt   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome

(2014) Nina Schlueter et al.   PHARMACOLOGY & THERAPEUTICS

Scalable high-density peptide arrays for comprehensive health monitoring

(2014) Joseph Barten Legutki et al.   Nature Communications

The Influence of biotinylation of 2F5 antibody on peptide selection from the combinatorial phage library

(2012) N. S. Shcherbakova et al.   Molecular Genetics Microbiology and Virology

Synthetic therapeutic peptides: science and market

(2009) Patrick Vlieghe et al.   DRUG DISCOVERY TODAY

Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway

(2008) F. Haspot et al.   BLOOD